Denali Advisors’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,200
Closed -$46.7K 511
2023
Q1
$46.7K Hold
8,200
0.02% 227
2022
Q4
$49.5K Hold
8,200
0.02% 221
2022
Q3
$54K Buy
+8,200
New +$54K 0.03% 205